Clinical implications of the intrinsic molecular subtypes of breast cancer
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer · Vall d'Hebron Institute of Oncology · +2 more institutions
Indexed incrossrefdoajpubmed
Abstract
No abstract available for this paper.
Citation impact
1,304
total citations
- FWCI
- 24.96
- Percentile
- 100%
- References
- 96
Citations per year
Authors
10- APAleix PratCorresponding
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Vall d'Hebron Institute of Oncology, CIBBIM-Nanomedicine, Universitat de Barcelona
- EPEstela Pineda
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona
- BABárbara Adamo
Universitat de Barcelona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer
- PGPatricia Galván
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, CIBBIM-Nanomedicine, Vall d'Hebron Institute of Oncology
- AFAranzazu Fernández-Martínez
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona
Topics & keywords
Topics
Keywords
- Medicine
- Lapatinib
- Trastuzumab
- Breast cancer
- Oncology
- Internal medicine
- Docetaxel
- Carboplatin
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.